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Sulforaphane, a biologically active isothiocyanate compound extracted from cruciferous vegetables, has been shown to exert
cytotoxic effects on many human cancer cells, including leukemia. However, the exact molecular mechanisms behind the
action of sulforaphane in hematological malignancies are still unclear. Like other cancer cells, leukemia cells produce high level
of reactive oxygen species; in particular, hydrogen peroxide derived from Nox family is involved in various redox signal
transduction pathways, promoting cell proliferation and survival. Recent evidence show that many tumour cell types express
elevated level of aquaporin isoforms, and we previously demonstrated that aquaporin-8 acts as H2O2 transport facilitator
across the plasma membrane of B1647 cells, a model of acute myeloid human leukemia. Thus, the control of AQP8-mediated
H2O2 transport could be a novel strategy to regulate cell signalling and survival. To this purpose, we evaluated whether
sulforaphane could somehow affect aquaporin-8-mediated H2O2 transport and/or Nox-mediated H2O2 production in B1647
cell line. Results indicated that sulforaphane inhibited both aquaporin-8 and Nox2 expression, thus decreasing B1647 cells
viability. Moreover, the data obtained by coimmunoprecipitation technique demonstrated that these two proteins are linked to
each other; thus, sulforaphane has an important role in modulating the downstream events triggered by the axis Nox2-
aquaporin-8. Cell treatment with sulforaphane also reduced the expression of peroxiredoxin-1, which is increased in almost all
acute myeloid leukemia subtypes. Interestingly, sulforaphane concentrations able to trigger these effects are achievable by
dietary intake of cruciferous vegetables, confirming the importance of the beneficial effect of a diet rich in bioactive compounds.
1. Introduction
The consumption of whole plant foods as chemopreventive
agents is highly recommended in the dietary guidelines on
the basis of health benefits from dietary phytochemicals
observed in epidemiological studies [1]. Among edible
plants, cruciferous vegetables have been proved to exert
potent anticarcinogenic effects owing to the presence of
isothiocyanates, which are the hydrolytic products of gluco-
sinolates. Among cruciferous vegetables, broccoli contains
the highest concentration of the glucosinolate glucorapha-
nin, which is hydrolysed by myrosinase and gut microbiota,
releasing sulforaphane, SFN (4-methylsulfinylbutyl isothio-
cyanate). In addition to its well-known anticancer activity
[2], SFN has been demonstrated to possess cardioprotective
[3], neuroprotective [4], and anti-inflammatory activities
[5], suggesting a pleiotropic protective role for this nutraceu-
tical compound.
The potent chemopreventive effect of SFN is based on its
ability to target multiple mechanisms within the cell to
control carcinogenesis. Many reports have shown that SFN
prevents tumour initiation by both inhibiting phase I
enzymes [6] and activating phase II detoxifying enzymes
[7]. Moreover, SFN prevents uncontrolled cancer cell
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proliferation through the modulation of genes involved in
apoptosis and cell cycle arrest [5, 8], angiogenesis [9, 10],
and metastasis [11, 12].
SFN cytotoxic effects have also been demonstrated on
hematological malignancies [13], and it has been reported
that SFN treatment of HL-60 and acute lymphoblastic leuke-
mia cells triggered apoptosis or cell cycle arrest [14–17].
Leukemia is one of the main cause of cancer-associated
death, and the high susceptibility to treatment-related toxic-
ity is still the major limit to the therapeutic success. There-
fore, the identification and development of novel agents
from natural products to counteract this disease are needed
in order to maximize the therapeutic benefit and minimize
antineoplastic drug resistance and treatment-related toxicity
in patients treated with intensified doses of multiple drugs.
In the human erythromegakaryocytic cell line B1647, a
model of acute myeloid leukemia, constitutively producing
VEGF and expressing its tyrosine kinase receptor, VEGFR-
2 [18], we demonstrated that VEGF signalling is coupled to
NAD(P)H oxidase (Nox) activity [19]. In particular, H2O2
generated via Nox2- and Nox4-dependent pathways is
involved in early signalling events, such as the maintenance
of the VEGFR-2 phosphorylation state, and also in the
modulation of downstream events leading to cell prolifera-
tion and survival [20, 21]. It has to be pointed out that
H2O2-derived Nox is formed outside the cell and have to
cross the membrane to reach its cytosolic targets. To this
regard, it has been reported that specific aquaporin isoforms
are capable of funneling H2O2 across the plasma membrane
in many cell types [22, 23]. In particular, AQP8 isoform has
demonstrated the ability to channel H2O2 through the
plasma membrane in B1647 cell line [24, 25], HeLa [26],
and B [27] cells.
Furthermore, tumour cells overexpress AQPs, and a posi-
tive correlation exists between histological tumour grade and
the AQP expression as compared to normal tissues [28–30].
The inhibition of AQP8-mediated H2O2 entry into the
cell, or the decreased AQP8 expression, entails that Nox-
derived H2O2 cannot exert its growth-promoting effects.
Therefore, the control of AQP8-mediated H2O2 transport
provides a novel mechanism to regulate cell signalling
and survival.
This study aimed at evaluating the potential anticancer
activity of SFN in B1647 leukemia cell line, focusing on
AQP8 function and expression. We also investigated the
effect of SFN on Nox2, Nox4, and peroxiredoxin expression
and on the phosphorylation state of VEGFR-2 and Akt.
2. Materials and Methods
2.1. Chemicals and Reagents. Dulbecco’s modified Eagle’s
medium (DMEM), Roswell Park Memorial Institute (RPMI)
1640 medium, penicillin, streptomycin, L-glutamine, phyto-
haemagglutinin (PHA), 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT), DAPI, RIPA lysis
buffer, 10% SDS solution, mammalian protease inhibitor
mixture, phosphatase inhibitor cocktail PhosSTOP (Roche),
Laemmli sample buffer containing 2-mercaptoethanol, Tris-
HCl, bovine serum albumin (BSA), Hank’s Balanced Salt
Solution (HBSS), 2,7-dichlorodihydrofluorescin diacetate
(DCFH-DA), plumbagin from Plumbago indica (5-
hydroxy-2-methyl-1,4-naphthoquinone), and all other
chemicals were purchased from Sigma-Aldrich. Iscove’s
Modified Dulbecco’s medium (IMDM) with L-glutamine,
foetal bovine serum (FBS), and human serum AB male
(HS) were purchased from Biowest. DL-Sulforaphane
(SFN) (LKT Laboratories) was dissolved in DMSO and
stored at −20°C at a stock concentration of 10mM. Abso-
lute RNA Miniprep Kit was from Agilent Technologies;
RNA-to-cDNA conversion kit was from Applied Biosys-
tems; SsoAdvanced™ Universal SYBR Green Supermix
was from Bio-Rad Laboratories; and RT-PCR primers for
AQP8, β-2-microglobulin, and actin were manufactured
from Sigma-Aldrich. SiRNA against Nox4 and scrambled
were obtained from Ambion by Life Technologies (USA).
Mini-PROTEAN® TGX™ precast gels 4–20%, Precision
Plus Protein™ Unstained Standards, Clarity™ Western
ECL Substrate, and DC™ protein assay were from Bio-
Rad Laboratories. Nitrocellulose membranes were from
GE Healthcare. Primary antibodies against: AQP8
(#WH0000343) and β-actin (#A5441) were from Sigma-
Aldrich, phospho-Akt (Ser473) (#4058) and Prx-1 (#8499)
from Cell Signalling Technologies, phospho-VEGFR-2 from
Thermo Scientific, gp91-phox (Nox2) from Millipore, and
Nox4 from Santa-Cruz. Secondary antibodies: horseradish
peroxidase-conjugated secondary antibodies anti-rabbit
(#7074) and anti-mouse (#7076) were purchased from Cell
Signalling Technologies; goat anti-Mouse IgG (H+L)
Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor®
Plus 488 (#A32723) was from Thermo Scientific.
2.2. Cell Culture. B1647 erythromegakaryocytic cell line,
established from the bone marrow of a patient with acute
myelogenous leukaemia (AML), is cultured in IMDM
supplemented with 5% (v/v) heat inactivated HS, L-gluta-
mine, 100U/mL penicillin, and 100 μg/mL streptomycin in
a humidified incubator maintained at 37°C and 5% CO2.
Human fibroblasts were grown and kindly provided by
Professor A. Lorenzini, University of Bologna.
Peripheral blood lymphocytes (PBL) were isolated by
density gradient centrifugation with Histopaque-1077 from
whole peripheral blood of healthy donors. PBL were cultured
at 37°C and 5% CO2 in RPMI-1640 supplemented with 1%
penicillin/streptomycin, 15% heat inactivated FBS, 1% L-glu-
tamine, and 0.5% PHA.
2.3. Cell Viability. Cell viability was evaluated by the MTT
assay. Cells were treated with increasing concentrations of
SFN (5, 10, or 30μM) for 24 h in 96-well plates, then
incubated with 0.5mg/mL MTT for 4 h at 37°C. The blue-
violet formazan salt crystals formed were dissolved with a
solubilisation solution (10% SDS, 0.01M HCl) keeping the
plates overnight at 37°C and 5% CO2 in a humidified atmo-
sphere. The absorbance at 570nm was measured using a
multiwell plate reader (Wallac Victor2, PerkinElmer).
2.4. Analysis of mRNA Expression by RT-PCR. After 24 h
treatment with SFN (1, 5, or 10μM), total RNA was extracted
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from B1647 cells using Absolutely RNAMiniprep Kit accord-
ing to the manufacturer’s recommendations. RNA quantifi-
cation was performed using a NanoVue spectrophotometer
(GE Healthcare). mRNA was reverse-transcribed into cDNA
starting from 1μg of total RNA using a high capacity RNA-
to-cDNA Conversion Kit. PCR was carried out in a total vol-
ume of 20μL containing 2μL of cDNA, 10μL SsoAdvanced™
Universal SYBR Green Supermix, and 1μL (500 nM) of each
primer. The specific primers used were produced by Sigma-
Aldrich: AQP8 (forward sequence: TTCTCCATCGGCTT
TGCCGTCA; reverse sequence: CAGCCAGTAGATCCAG
TGGAAG; amplicon of 135 pb), β-actin (forward sequence:
5′-AAGACCTCTATGCCAACAC-3′; reverse sequence: 5′
-TGATCTTCATGGTGCTAGG-3′), and β2-microglobulin
(forward sequence: 5′-ACTGGTCTTTCTACATCCTG-3′;
reverse sequence: 5′-AGATGATTCAGAGCTCCATAG-3′).
β-Actin and β2-microglobulin were used as reference genes.
The reaction mixtures were kept for 45min at 45°C, 2min
at 94°C, then cycled 35 times through a program of 30 s at
94°C, 1min at 56°C, and 1min at 72°C; finally, the reaction
was incubated for an extra 7min at 68°C. Normalized expres-
sion levels were calculated relative to control cells according
to the 2-ΔΔCT method.
2.5. Cell Transfection. B1647 cells were nucleofected with Cell
Line Nucleofector™ Kit V (Amaxa Biosystems, Cologne,
Germany) with Program T-019 following the manufacturer’s
instructions. SiRNA against Nox4 (sequence 5′-3′: CAACUC
AUAUGGGACAAGAtt; antisense UCUUGUCCCAUAUG
AGUUGtt) and scrambled were obtained from Ambion by
Life Technologies (USA). RNA silencing was obtained with
300nM siRNA. Subsequently, cells were immediately sus-
pended in a complete medium and incubated in a humidified
37°C/5% CO2 incubator. After 24 h, cells were used for the
experiments: evaluation of Nox4 expression by Western blot
analysis and intracellular ROS level measurement.
2.6. Electrophoresis and Western Blot Analysis. After 24 h
treatment with SFN (1, 5, or 10μM), B1647 cells (1× 106/
mL) were washed with ice-cold PBS and lysed with RIPA
buffer containing mammalian protease and phosphatase
inhibitor mixtures. Protein concentration of the cleared
lysates was determined by Bio-Rad DC™ protein assay.
Proteins (10μg per lane) were electrophoretically separated
on 4–20% SDS-PAGE Mini-Protean® TGX™ precast gels
using a Mini-Protean II apparatus (Bio-Rad Laboratories)
and transferred to Hybond-C nitrocellulose membrane.
Nonspecific binding was avoided by incubating membranes
in blocking buffer containing 5% (w/v) albumin in Tris-
buffered saline (TBS)/Tween, then the nitrocellulose mem-
branes were probed overnight at 4°C with primary antibodies
(anti-AQP8, anti-Nox2, anti-phospho-VEGFR-2, anti-phos-
pho-Akt, anti-Nox4, or anti-β-actin as internal normalizer).
Nitrocellulose membranes were washed with TBS/Tween
and incubated at room temperature for 1 h with horseradish
peroxidase-conjugated secondary antibodies in TBS/Tween
containing 5% nonfat dried milk or 5% albumin and succes-
sively washed with TBS/Tween. Chemiluminescence detec-
tion was performed using Clarity™ Western ECL Substrate.
Bands were acquired with a CCD imager (ChemiDoc™ MP
System, Bio-Rad Laboratories), and relative densitometric
analysis were performed by using Image Lab analysis
software (Bio-Rad Laboratories).
2.7. Immunofluorescence Confocal Microscopy. B1647 cells
were treated with 10μM SFN for 24 h, loaded into cytospin
chambers, and centrifuged at 450 rpm for 10min. Cells
were then fixed in formaldehyde 3.7% for 15min, washed
twice with PBS, blocked with PBS/BSA 1% (w/v) for 1 h,
and incubated with mouse anti-AQP8 antibody for 1 h.
Consecutively, cells were treated with fluorescent goat
anti-Mouse Secondary Antibody, Alexa Fluor® Plus 488
conjugated for 1 h in the dark, nuclei were stained with
DAPI, and coverslips were mounted on slides. Confocal
imaging was acquired by a Nikon A1 confocal laser scan-
ning microscope (Nikon Instruments, Japan).
2.8. Measurement of Intracellular ROS Level. B1647 cells were
treated with 5 or 10μM SFN for 24 h and, when specified,
with 1μM plumbagin for 30min. To evaluate intracellular
ROS level, 1× 106 cells/mL were washed twice in HBSS and
incubated for 20min with 5μM DCFH-DA at 37°C.
DCFH-DA is a small, nonpolar, and nonfluorescent
molecule that passes through the cell membrane into the
cells by diffusion; in the cytosol, it is enzymatically deacety-
lated by intracellular esterases to a polar nonfluorescent
compound, which is oxidised by intracellular ROS to the
highly green fluorescent 2,7-dichlorofluorescein (DCF).
DCF fluorescence was measured using a multiwell plate
reader (Wallac Victor2, PerkinElmer). Excitation wave-
length was 485nm, and emission wavelength was 535nm.
Fluorescence values were reported as the percentage of intra-
cellular ROS in respect to controls.
2.9. Immunoprecipitation. Control or SFN-treated B1647
cells (1× 106 cells/mL) were lysed as described above. Lysates
containing equal protein amounts were incubated overnight
with anti-AQP8 antibody. Then, samples were incubated
with protein G-agarose for 1.5 h at 4°C and pelleted at
12,000 x g for 30min. Pellets were washed 5 times with buffer
(pH=8) and centrifuged at 12,000 x g for 5min. Samples
were subjected to SDS-PAGE and Western blotting analysis
with anti-Nox2 as described above. Bands were acquired
with a CCD imager (ChemiDoc™ MP System, Bio-Rad
Laboratories), and relative densitometric analysis were per-
formed by using Image Lab analysis software (Bio-Rad
Laboratories).
2.10. Statistical Analysis. Each experiment was performed at
least three times, and all values are represented as means
± SD. One-way ANOVA was used to compare differences
among groups followed by Bonferroni’s test (Prism 5; Graph-
Pad Software). Values of p < 0 05 were considered as statisti-
cally significant.
3. Results
It has been reported that SFN is able to selectively exert cyto-
toxic effects in many human cancer cells without affecting
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normal cells [8]. On these bases, leukemia B1647 cells and
human lymphocytes or fibroblasts, chosen as model of non-
transformed cells, were incubated with increasing SFN con-
centrations, and cell viability was evaluated by MTT assay
(Figure 1). Both 10 and 30μM SFN showed cytotoxic effects
in B1647, as cell viability was significantly lower compared to
control cells. In human lymphocytes and fibroblasts, 30μM
SFN significantly reduced cell viability; meanwhile, 10μM
SFN did not show any cytotoxic effect. Therefore, SFN con-
centrations below or at least the same as 10μM were used
in the subsequent experiments.
To investigate the mechanism underpinning the
observed cytotoxic effect of SFN in B1647 cells, we evaluated
AQP8 expression after SFN treatment, as we hypothesized
that SFN could impair the cellular redox status affecting
H2O2 transport through AQP8 channel. In order to verify
this hypothesis, B1647 cells were treated with different SFN
concentrations for 24 h, and the expression of AQP8 was
evaluated by RT-PCR (Figure 2(a)) and Western blot
(Figure 2(b)) analyses.
Results show that AQP8 was significantly decreased both
at transcriptional and protein level upon cell treatment with
10μM SFN, whereas 1 or 5μM SFN did not cause any signif-
icant change.
To corroborate these findings, B1647 cells were treated
with 10μM SFN, then AQP8 content in plasma membrane
was evaluated using an immune-fluorescence technique and
visualized through confocal microscopy (Figure 3).
As expected, SFN treatment strongly reduced green fluo-
rescence in B1647 plasma membrane, confirming the ability
of SFN to reduce AQP8 level, in agreement with RT-PCR
and Western blot data.
Since SFN decreases AQP8 level, it is reasonable that a
smaller amount of H2O2 is transported into the cell. To
investigate this aspect, B1647 cells were incubated for 24h
with increasing SFN concentrations and then assayed for
ROS level by using the fluorescent DCF probe. Results in
Figure 4 show that only 10μM SFN treatment causes a signif-
icant decrease of ROS intracellular levels in respect to control
cells, according to previous observations.
To better elucidate the mechanisms behind SFN ability to
reduce ROS intracellular level, we investigated SFN influence
on the sources of H2O2 present in B1647 cells. To this regard,
we have previously demonstrated that the main sources of
H2O2 in B1647 cell line are Nox2 and Nox4 isoforms [19].
Nox-derived ROS are involved in early signalling events,
such as the auto-phosphorylation of VEGFR-2 leading to
downstream events, including the maintenance of the active
phosphorylated form of Akt [20]. Therefore, the possible
effect of SFN on Nox isoforms expression and the phosphor-
ylation level of VEGFR-2 and Akt were investigated in B1647
cell line (Figure 5).
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Figure 1: Effect of SFN on the viability of transformed and nontransformed human cells. B1647 cells, human lymphocytes or fibroblasts were
incubated for 24 h with increasing SFN concentrations. Viability was evaluated by MTT test, as reported in Materials and Methods section.
Results are expressed as means± SD of three independent experiments. Statistical analysis was performed by Bonferroni multiple comparison
test following one-way ANOVA. ∗p < 0 05, significantly different from control cells.
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Western blot analysis reveals that, when treated with
10μM SFN, B1647 cells express Nox2 to a lesser extent than
controls and exhibit a diminished phosphorylation level of
both VEGFR-2 and Akt. On the other hand, the amount of
Nox4 was significantly increased. This result could explain
the slight decrease in the level of intracellular ROS observed
upon SFN treatment. To better appreciate SFN effect on
Nox2, Nox4 isoform was inhibited by plumbagin, a Nox4
inhibitor [31], or by silencing with siRNA against Nox4.
DAPI AQP8
AQP8DAPI
CT
RL
SF
N
Figure 3: Effect of SFN on AQP8 content in plasma membrane of
B1647 cell line. Representative confocal images of B1647 cells
treated (SFN) or not (CTRL) with 10 μM sulforaphane for 24 h
and labelled with DAPI (blue) and anti-aquaporin 8, AQP8,
(green). Cells were not permeabilized in order to exclude
intracellular signals. Scale bar = 10 μm. Triple magnification of
representative superimposed 3 central slices is shown in white
squares. Images were acquired by Nikon A1 confocal laser
scanning microscope (Nikon Instruments, Japan). The results are
the representative of two independent experiments.
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AQP8
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(b)
Figure 2: Effect of SFN on AQP8 expression in B1647 cell line. B1647 cells were incubated for 24 h with different SFN concentrations and (a)
RNA was extracted from the cells and samples subjected to RT-PCR analysis using specific primers as described in Materials and Methods
section. Normalized expression levels were calculated relative to control cells according to the 2-ΔΔCq method; (b) proteins were extracted,
separated by SDS-PAGE, transferred to nitrocellulose membrane, and immunoassayed using anti-AQP8 and anti-β-actin antibodies as
reported in Materials and Methods section. Immunoblot is the representative of three independent experiments, and densitometric
analysis, normalized to β-actin, is expressed as fold decrease with respect to control. ∗p < 0 05, significantly different from control cells.
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Figure 4: Effect of SFN on intracellular ROS level in B1647 cell line.
B1647 cells were incubated for 24 h with different SFN
concentrations. Intracellular ROS level was evaluated as DCF
fluorescence as reported in Materials and Methods section. Data
are expressed as % of control and represent means± SD of at least
three independent experiments. Data were analysed by one-way
ANOVA followed by Bonferroni’s test. ∗∗p < 0 01, significantly
different from control cells.
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Figure 6 shows the evaluation of intracellular ROS level in the
presence of plumbagin (Figure 6(a)) or after specific Nox4
silencing (Figure 6(b)). Interestingly, SFN treatment led to a
more pronounced reduction of intracellular ROS content
when Nox4 was inhibited or silenced.
It has been recently reported that aquaporins can have
protein interaction partners [31]; therefore, the possible
interaction between AQP8 and Nox2, the main ROS source
in B1647 cells, was investigated by immunoprecipitation
technique. Results in Figure 7 show that Nox2 coprecipitates
with AQP8, indicating a strong link between these two pro-
teins. As expected, upon the 10μM SFN treatment, the band
corresponding to Nox2 significantly lost intensity, according
to the decreasing SFN effect on AQP8 and Nox2 expression.
To corroborate this result, the “vice-versa” immunoprecipita-
tion was performed, i.e., IP for Nox2 and WB for AQP8, and
also, in this case, the coprecipitation of the two proteins was
observed (not shown).
Peroxiredoxins (Prxs) have catalytic cysteines exhibiting
great susceptibility to oxidation by hydrogen peroxide [32];
therefore, they are important regulators of peroxide-
dependent signalling pathways. Furthermore, Prxs have been
found to be elevated in many human cancer cells and tissues,
where they enhance the aggressive survival phenotype and
confer increased resistance to chemo- and radio-therapy
[33]. In order to ascertain whether SFN could affect Prx-1
expression, B1647 cells were incubated with SFN for 24h,
then subjected to Western blot analysis, as reported in
Figure 8.
The results show that the cell treatment with 10μM SFN
for 24 h significantly decreased Prx-1 expression.
4. Discussion
In a previous study carried out in B1647 cell line, we have
demonstrated that AQP8 expression modulates the ampli-
tude of the downstream VEGF signalling, which proceeds
through the involvement of Nox-produced H2O2 as a second
messenger [25]. Thus, this AQP isoform has gained an
important role as a fine level regulator in the transduction
of the redox signal. It has been reported that living cells can
regulate the permeability of AQP8 to H2O2 and water
through a temporary modification of functional cysteines,
particularly during cell stress conditions [34, 35]. It seems
of great interest the identification of molecules able to mod-
ulate the activity and/or expression of AQP8 isoform in order
to influence the cellular response. In particular, the attention
points toward the identification of natural products or food-
derived molecules to be used as chemopreventive agents. On
these premises, we investigated the potential effect of the
isothiocyanate SFN on the modulation of AQP8 and Nox
expression in the leukemic B1647 cell line. As a result of
many in vivo and in vitro studies, it was stated that SFN is
able to selectively exert cytotoxic effects in various human
cancer cells, while having no cytotoxic effects, or being even
cytoprotective in normal cells [5, 8]. The treatment of HL-
60 cells with increasing concentrations of SFN (0–100μM)
was reported to induce a dose-dependent decrease in cell via-
bility, with a IC50 value determined as 49.5μM [36]; in pre-B
ALL (acute lymphoblastic leukemia) and T-ALL cell lines, it
was observed that SFN induce cytotoxicity at concentration
ranging from 4 to 10μM in contrast to 90μM for nonleuke-
mic controls [37]. These data evidence that high SFN concen-
trations are needed to exert cytotoxic effects on normal cells,
whereas low concentrations provoke a selective effect on
transformed cells. Our data show that 30μM SFN signifi-
cantly reduced the viability of both leukemic and normal
cells, while 10μM exerted a cytotoxic effect only in cancer
cells. Therefore, SFN concentrations below or equal to
10μM were used in all the experiments. Interestingly, con-
centrations of similar order of magnitude can be really
achieved in human plasma through dietary intake of crucifer-
ous vegetables. Since it has been estimated that 40 g of fresh
broccoli sprouts yield a transient serum level of SFN of about
2μmol/L [38], a serving of 200 g of broccoli can provide the
desired SFN plasma level of about 10μmol/L.
As our results show that SFN is able to downregulate
AQP8 expression, we can speculate that the lower level of
intracellular ROS we measured by DCFH-DA is due to a
smaller amount of H2O2 transported into the cell. DCFH-
DA is not specific for H2O2 but reacts with all oxidants pres-
ent in biological systems [39, 40]. However, in a previous
paper of us, reporting data performed in the same leukemic
cell line, i.e., B1647, we measured the intracellular ROS level
with both DCFH-DA and PF1, a boronate dye more selective
for H2O2 than DCFH-DA, obtaining similar results [24].
Furthermore, in the subsequent paper, we detected the intra-
cellular thiol redox state of B1647 cells with a dimedone
Sulforaphane (SFN)
C 1 휇M 10 휇M5 휇M
Nox2
p-VEGFR-2
p-Akt
Nox4
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1.0 ± 0.1 1.2 ± 0.1 1.1 ± 0.1 0.7 ± 0.1⁎
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Figure 5: Effect of SFN on Nox2 and Nox4 expression and
phosphorylation level of VEGFR-2 and Akt in B1647 cell line.
B1647 cells were incubated for 24 h with different SFN
concentrations. At the end of incubation, cells were lysed, and
proteins were separated by SDS-PAGE, transferred to
nitrocellulose membrane, and immunoassayed using specific
antibodies as reported in Materials and Methods section.
Immunoblots are the representative of three independent
experiments, and densitometric analysis, normalized to β-actin, is
expressed as fold decrease with respect to control. ∗p < 0 05,
significantly different from control cells.
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method, which is able to react with cysteine sulfenic acid,
which is formed upon H2O2 action as a signalling molecule.
We observed a linear correlation between the protein thiol
redox state and the applied stimulus, i.e., H2O2 10–100μM.
This technique allowed us to demonstrate that the amplitude
of intracellular cysteine oxidation is dependent on AQP8
expression level, which modulates the amount of H2O2 that
is able to reach its intracellular targets [25].
The decrease of Nox2 expression observed in this study
is, in part, counterbalanced by a significant increase in
Nox4 expression. Indeed, we have previously demonstrated
that B1647 cell line expresses Nox2 and the constitutively
active Nox4, but not other isoforms [19]. It could be argued
that cell undergoing SFN treatment might deploy mecha-
nisms to counteract the limited H2O2 production (by
Nox2) and transport (by AQP8) through the strengthening
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Figure 6: Effect of SFN on intracellular ROS level in B1647 cell line after Nox4 inhibition or silencing. (a) B1647 cells were incubated for 24 h
with different SFN concentrations, then treated or not with 1 μM plumbagin for 30min. (b) B1647 cells were transfected with specific siRNA
against Nox4 or a random RNA sequence (scrambled) as negative control, C (Scr). 24 h after transfection with siRNA, B1647 cells were
incubated for 24 h with different SFN concentrations. Intracellular ROS level was then evaluated as DCF fluorescence as reported in
Materials and Methods section. Data are expressed as % of control and represent means± SD of three independent experiments. Data
were analysed by one-way ANOVA followed by Bonferroni’s test. ∗∗∗p < 0 001; ∗∗p < 0 01; ∗p < 0 05, significantly different from relative
control cells. §p < 0 05, significantly different from the corresponding bars in the absence of plumbagin (a) or in Nox4-silenced cells (b).
(c) B1647 cells were transfected by electroporation with siRNA against Nox4 or a random RNA sequence (scrambled) as negative control.
Effect of RNA interference of Nox4 was confirmed by Western blot analysis with specific antibodies against Nox4.
Sulforaphane (SFN)
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1.0 ± 0.1
IP: AQP8
WB: Nox2
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Figure 7: Effect of SFN on the interaction between AQP8 and
Nox2 in B1647 cell line. B1647 cells were incubated for 24 h with
different SFN concentrations. At the end of incubation, cells were
subjected to immunoprecipitation with anti-AQP8. Proteins were
then extracted, separated by SDS-PAGE, immunoblotted, and
revealed for anti-Nox2 as described in Materials and Methods
section. Immunoblot is the representative of three independent
experiments, and densitometric analysis is expressed as fold
decrease with respect to control. ∗p < 0 05, significantly different
from control cells.
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of Nox4 expression. Blocking Nox4 activity by the inhibitor
plumbagin or knocking down this isoform by specific Nox4
silencing led to a more pronounced SFN effect on intracel-
lular ROS content (Figure 6). In this condition, Nox2
remains the main ROS source in B1647 cells, and SFN
effect can be better appreciated. Although it was reported
that 10μM plumbagin greatly inhibited Nox4 activity in
HEK293 and LN229 cells [41], in our conditions, this
plumbagin concentration markedly decreased B1647 cell
viability (data not shown), and therefore, we used 1μM
plumbagin, according to Guida and coworkers [42].
By using a coimmunoprecipitation technique, we also
demonstrated that Nox2 and AQP8 are linked to each other,
confirming the existence of a Nox2-AQP8 axis in B1647 cell
line. The evidence of the interaction between AQP8 and
Nox2 supports the importance of these two partners in the
redox signalling cascade. The activity of Nox2-AQP8 axis
is also a determinant in B cell activation and differentiation
[27]. Many isoforms of aquaporins have protein-protein
interactions, specifically found for AQP0, AQP2, AQP4,
and AQP5 [31]. The characteristics of these interaction part-
ners are strikingly different, but they generally influence the
translocation, trafficking, internalization, or phosphoryla-
tion of AQP isoforms. B1647 is a self-producing VEGF cell
line, which is subjected to continuous VEGF signalling;
therefore, the axis Nox2-AQP8 has a central role in modu-
lating the downstream events supporting their viability and
proliferation. This distinctive feature of these cells could
explain the observed SFN-induced intracellular ROS
decrease. Although other reports, obtained in different cell
types, demonstrate a SFN-induced ROS increase [43–45], it
has been shown that SFN inhibits VEGF expression [8, 9],
which is strictly linked to Nox activation. Therefore, VEGF
inhibition coupled with SFN-induced decrease of both
Nox2 and AQP8 expression may contribute to the observed
decrease in intracellular ROS level in B1647 cell line. More-
over, SFN is known to induce changes in the intracellular
redox state, and, depending on its concentration, exposure
time, or cell type, it may promote antioxidant or prooxidant
response. From the data of the literature, it can be summa-
rized that a predominantly antioxidant response has been
reported at low SFN concentration, i.e., up to 5μM SFN
for up to 24 h, which is close to our conditions, whereas
higher SFN concentrations and long-lasting exposure
periods produce a prooxidant effect [45, 46].
The ability of SFN to interfere with the redox signal-
ling is confirmed also by its effect on VEGFR-2 and Akt
phosphorylation status, which is significantly reduced in
SFN-treated cells. The decreased amount of p-VEGFR-2
was an expected result, since ROS source involved in
VEGFR-2 activation has been identified in Nox activity
[20]. The smaller amount of p-Akt observed in SFN-
treated cells indicates that this isothiocyanate exerts its
action also on the downstream H2O2 targets, among which
Akt represents a key enzyme controlling many hallmarks
of cancer. Indeed, the active phosphorylated form of this
enzyme plays a pivotal role in tumour cell survival, prolif-
eration, and invasiveness [47].
Prxs are abundant thiol-dependent peroxidases highly
efficient at reducing hydrogen peroxide, peroxynitrite, and
other hydroperoxides [48]. Due to their high reactivity and
abundance, Prxs will be the major targets of intracellular
hydrogen peroxide [49] and, therefore, important regulators
of peroxide-dependent signalling pathways [50]. Besides
their antioxidant activity, recently, evidence indicates that
Prxs have a significant influence on the development and
progression of cancer. Prx-knock-out mice often exhibit
increased carcinogenesis, whereas elevated Prx expression is
commonly observed in human tumours [49]. In leukemia
cells, Prxs display variable expression, suggesting difference
in functional significance depending on the cellular context
[51]. In particular, a proteomic analysis has demonstrated
that Prxs are significantly increased in almost all acute
myeloid leukemia (AML) subtypes; thus, they were proposed
as potential targets for AML patients [52]. Our results show
that B1647 cell line expresses Prx-1, which is significantly
reduced upon SFN treatment, indicating an additional pro-
tective role of this isothiocyanate against malignancy. How-
ever, further studies are needed to elucidate a definitive role
for Prx family in leukemia.
5. Conclusions
The data reported here show that SFN downregulates AQP8
and Nox2 expression in B1647 cell line, limiting both H2O2
production and entry into the cells. Consequently, the
amount of hydrogen peroxide able to reach its intracellular
targets is decreased, and leukemia cell viability significantly
reduced. Indeed, by decreasing the effect of Nox2-AQP8
axis, SFN causes profound effects on the transduction of
the redox signalling and, consequently, on cell survival and
proliferation, opening the way to unforeseen opportunities
in the fighting of acute myeloid leukemia. Of note, SFN con-
centrations able to trigger these effects are comparable to
plasma concentrations measured after cruciferous vegetables
dietary intake.
Sulforaphane (SFN)
C
Prx-1
Actin
10 휇M5 휇M
1.0 ± 0.1 0.9 ± 0.1 0.6 ± 0.2⁎
Figure 8: Effect of SFN on peroxiredoxin-1 (Prx-1) in B1647 cell
line. B1647 cells were incubated with 5 or 10μM SFN for 24 h. At
the end of incubation, cells were lysed, and proteins were
separated by SDS-PAGE, immunoblotted, and revealed for anti-
Prx-1 as reported in Materials and Methods section. Immunoblot
is the representative of three independent experiments, and
densitometric analysis, normalized to β-actin, is expressed as fold
decrease with respect to control. ∗p < 0 05, significantly different
from control cells.
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